Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain

Archives of Internal Medicine

Volumn 159, Issue 16, 1999, Pages 1931-1937

  Morello, Candis M ^a   Leckband, Susan G ^a   Stoner, Carol P ^a   Moorhouse, David F ^a,b   Sahagian, Gregory A ^a,b  

^a VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^b UCSD MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; GABAPENTIN;

ADULT; AGED; ANALGESIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIABETIC NEUROPATHY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MALE; MAXIMUM PERMISSIBLE DOSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEDATION; TREATMENT OUTCOME; VERTIGO; XEROSTOMIA;

EID: 0033552134     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.159.16.1931     Document Type: Article

References (40)

1. Herman WA, Greene DA. Microvascular complications of diabetes. In: Haire-Joshu D, ed. Management of Diabetes Mellitus. 2nd ed. St Louis, Mo: CV Mosby; 1996:234-280.
2. Pirart J. Diabetes mellitus and its degenerative complications: a prospective study of 4,400 patients observed between 1947 and 1973. Diabetes Care. 1978;1:168-188, 252-263.
3. McLeod JG. Investigation of peripheral neuropathy. J Neurol Neurosurg Psychiatry. 1995;58:274-283.
4. Dyck PJ. New understanding and treatment of diabetic neuropathy. N Engl J Med. 1992;326:1287-1288.
5. Veves A, Sarnow MR. Diagnosis, classification, and treatment of diabetic peripheral neuropathy. Clin Podiatr Med Surg. 1995;12:19-30.
6. Max MB, Culnane M, Schafer SC, et al. Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood. Neurology. 1987;37:589-596.
7. Max MB, Lynch SA, Muir J, Shoaf SE, Smoller B, Dubner R. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med. 1992;326:1250-1256.
8. Sindrup SH, Bjerre U, Dejgaard A, Brøsen K, Aaes-Jørgensen T, Gram LF. The selective serotonin reuptake inhibitor citalopram relieves the symptoms of diabetic neuropathy. Clin Pharmacol Ther. 1992;52:547-552.
9. McQuay H, Carroll D, Jadad AR, Wiffen P, Moore A. Anticonvulsant drugs for management of pain: a systematic review. BMJ. 1995;311:1047-1052.
10. Wright JM, Oki JC, Graves L III. Mexiletine in the symptomatic treatment of diabetic peripheral neuropathy. Ann Pharmacother. 1997;31:29-34.
11. Stracke H, Meyer UE, Schumacher HE, Federlin K. Mexiletine in the treatment of diabetic neuropathy. Diabetes Care. 1992;15:1550-1555.
12. Capsaicin Study Group. Treatment of painful diabetic neuropathy with topical capsaicin. Arch Intern Med. 1991;151:2225-2229.
13. Chadwick D. Gabapentin clinical use. In: Levy RH, Mattson RH, Meldrum BS, eds. Antiepileptic Drugs. 4th ed. New York, NY: Raven Press; 1995:851-856.
14. Taylor CP. Gabapentin: mechanisms of action. In: Levy RH, Mattson RH, Meldrum BS, eds. Antiepileptic Drugs. 4th ed. New York, NY: Raven Press; 1995: 829-841.
15. Dichter MA, Brodie MJ. New antiepileptic drugs. N Engl J Med. 1996;334:1583-1590.
16. Taylor CP. Emerging perspectives on the mechanism of action of gabapentin. Neurology. 1994;44(suppl 5):S10-S16.
17. Field MJ, Oles RJ, Lewis AS, McCleary S, Hughes J, Singh L. Gabapentin (neurontin) and S-(+)-3-isobutylgaba represent a novel class of selective antihyper-algesic agents. Br J Pharmacol. 1997;121:1513-1522.
18. Wetzel CH, Connelly JF. Use of gabapentin in pain management. Ann Pharmacother. 1997;31:1082-1083.
19. Mellick GA, Mellick LB. Gabapentin in the management of reflex sympathetic dystrophy [letter]. J Pain Symptom Manage. 1995;10:265-266.
20. Mellick GA, Mellick LB. Reflex sympathetic dystrophy treated with gabapentin. Arch Phys Med Rehabil. 1997;78:98-105.
21. Rosner H, Rubin L, Kestenbaum A. Case report: gabapentin adjunctive therapy in neuropathic pain states. Clin J Pain. 1996;12:56-58.
22. Rosenberg JM, Harrell C, Ristic H, Werner RA, de Rosayro AM. The effect of gabapentin on neuropathic pain. Clin J Pain. 1997;13:251-255.
23. Sist T, Filadora V, Miner M, Lema M. Gabapentin for idiopathic trigeminal neuralgia: report of two cases. Neurology. 1997;48:1467.
24. Sist TC, Filadora VA, Miner M, Lema M. Experience with gabapentin for neuropathic pain in the head and neck: report of 10 cases. Reg Anesth. 1997;22:473-478.
25. Samkoff LM, Daras M, Tuchman AJ, Koppel BS. Amelioration of refractory dysesthetic limb pain in multiple sclerosis by gabapentin. Neurology. 1997;49:304-305.
26. Khatri A, Pearlstein L. Pain in Guillain-Barré syndrome [letter]. Neurology. 1997; 49:1474.
27. McGraw T, Kosek P. Erythromelalgia pain managed with gabapentin. Anesthesiology. 1997;86:988-990.
28. Segal AZ, Rordorf G. Gabapentin as a novel treatment for postherpetic neuralgia. Neurology. 1996;46:1175-1176.
29. Zapp JJ. Postpoliomyelitis pain treated with gabapentin [letter]. Am Fam Physician. 1996; 53:2442-2443.
30. Mellick LB, Mellick GA. Successful treatment of reflex sympathetic dystrophy with gabapentin [letter]. Am J Emerg Med. 1995;13:96.
31. Mellick GA, Seng ML. The use of gabapentin in the treatment of reflex sympathetic dystrophy and a phobic disorder. Am J Pain Manage. 1995;5:7-9.
32. Backonja M, Beydoun A, Edwards KR, et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: randomized controlled trial. JAMA. 1998;280:1831-1836.
33. Cockroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31-41.
34. Lustman PJ, Clouse RE, Griffin LS, Carney RM, Freedland KE. Screening for depression in diabetes using the Beck Depression Inventory. Psychosom Med. 1997; 59:24-31.
35. Gracely RH, McGrath P, Dubner R. Ratio scales of sensory and affective verbal pain descriptors. Pain. 1978;5:5-18.
36. Gracely RH, Dubner R, McGrath PA. Narcotic analgesia: fentanyl reduces the intensity but not the unpleasantness of painful tooth pulp sensations. Science. 1979; 203:1261-1263.
37. Heft MW, Gracely RH, Dubner R, McGrath PA. A validation model for verbal descriptor scaling of human clinical pain. Pain. 1980;9:363-373.
38. Gracely RH, Dubner R, McGrath PA. Fentanyl reduces the intensity of painful tooth pulp sensations: controlling for detection of active drugs. Anesth Analg. 1982; 61:751-755.
39. Heft MW, Gracely RH, Dubner R. Nitrous oxide analgesia: a psychophysical evaluation using verbal descriptor scaling. J Dent Res. 1984;63:129-132.
40. Freiman JA, Chalmers TC, Smith H, Kuebler RR. The importance of beta, the type II error and sample size in the design and interpretation of the randomized clinical trial. N Engl J Med. 1978;299:690-694.